Amyloid-beta and tau protein beyond Alzheimer’s disease
Morteza Abyadeh(Virginia Commonwealth University), Mehdi Mirzaei(Australian Hearing), Sina Shadfar(Yeungnam University), Veer Bala Gupta(Deakin University), João A. Paulo(Harvard University), Vivek Gupta(Edith Cowan University), Paul A. Haynes(Macquarie University), Christine T. O. Nguyen(The University of Melbourne), David I. Finkelstein(The University of Melbourne), Stuart L. Graham(University of Warwick), Shahab Mirshahvaladi(Macquarie University), Ghasem Hosseini Salekdeh(Macquarie University), Arezoo Gohari Mahmoudabad, Yuyi You(The University of Sydney)
Cited by 98
Related Papers
The burden of bacterial antimicrobial resistance in the WHO European region in 2019: a cross-country systematic analysis
|The Lancet Public Health|2022|350
Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019
|EClinicalMedicine|2023|132
The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson’s disease
|Acta Neuropathologica Communications|2017|99
Choroid plexus volume in multiple sclerosis predicts expansion of chronic lesions and brain atrophy
|Annals of Clinical and Translational Neurology|2022|89
Cdkal1, a type 2 diabetes susceptibility gene, regulates mitochondrial function in adipose tissue
|Molecular Metabolism|2017|73